Three insiders at Celsius Holdings bought $1.83 million of stock in five days. The stock is down 53% over the past year. Short interest is 16.7% of float. Twenty-one analysts rate it a Buy.
None of that is the interesting part.
The Cluster
| Insider | Role | Shares | Amount | Date |
|---|---|---|---|---|
| John Fieldly | CEO | 18,000 | $494K | Sept 10 |
| Damon DeSantis | Director | 36,000 | $1.0M | Sept 14–15 |
| Hal Kravitz | Lead Director | 12,000 | $336K | Sept 15 |
| Total | 66,000 | $1.83M | 5 days | |
Every purchase was discretionary. Open market. Not 10b5-1 plans. Not options exercises. Not RSU vesting. Three people looked at a stock down 53% and decided to wire money.
The Name
Damon DeSantis is not just any director. He is Carl DeSantis's son.
Carl DeSantis backed Celsius when it was a nothing stock on a pink sheet, funded it through delisting, watched it become the energy drink that wouldn't die. At its peak he owned a third of the company. His sons Damon and Dean owned another 17%. When Carl died in 2023, he was a billionaire because of this one bet.
Since his death, the estate has been unwinding. CD Financial LLC — managed by Deborah DeSantis — entered prepaid variable forward sale contracts in June 2023. Throughout July 2026, those contracts were settled: 150,000-share tranches delivered at contract prices near $46. Dean DeSantis, former 10% owner, executed similar dispositions. Hundreds of thousands of shares delivered on schedules set three years ago.
The estate is delivering shares at $46 on contracts from 2023. The founder's son is buying shares at $28 in 2026. Both sides of the same stock. The question is which one reflects conviction about the future.
The CEO's Pattern
Fieldly's September 10 purchase was not his first this year. In late May, he bought 8,475 shares at $29.36. He now holds 956,063 shares.
Two open-market purchases in four months, each at lower prices than the last. Averaging down, not panic-selling. After a quarter where core Celsius brand revenue fell 4% and the stock cratered on a miss, the CEO wired another half million.
What They're Buying Into
Q2 was complicated. Record revenue — $817.9 million, up 11% — but carried almost entirely by Alani Nu ($364 million, its first full quarter on PepsiCo distribution). The flagship Celsius brand declined. Adjusted EBITDA fell 12%. The market punished the miss, and lawsuits followed.
But the three-brand portfolio now controls roughly 20% of the US ready-to-drink energy market. Alani Nu crossed $1 billion in tracked retail sales in H1 2026 with 56% growth. Rockstar integration completed ahead of schedule. The company repurchased $124 million of its own stock in the first half.
The market is pricing the Celsius brand's decline. The insiders appear to be pricing the portfolio's trajectory.
The Short Side
30 million shares short
16.7% of float • Up 72% year-over-year • 1.8 days to cover
Short interest has nearly doubled in a year. But the days-to-cover ratio is just 1.8 — meaning the liquidity exists for a rapid unwind if conviction flips. The insiders are betting that $28 is where it flips.
The Divergence
Analyst consensus price target: $42.29. That's 50% above where three insiders just bought with their own money. Deutsche Bank downgraded to Hold. Class-action lawyers circling. Short interest at 16.7%.
Three people with full visibility into the company's operations, pipeline, and trajectory chose this moment to deploy $1.83 million. The founder's son — who has watched this stock his entire adult life, who inherited the position that made his father a billionaire, who could have done nothing — chose to buy a million dollars more.
Old contracts deliver at $46. Fresh capital arrives at $28. The spread between those two numbers is the distance between a hedge set in a different era and a bet placed right now.
Data sourced from SEC Form 4 filings. Short interest via FINRA. Analyst consensus via S&P Global. Insider transactions are public information and do not constitute investment advice.